JANE STREET GROUP, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$858,712
-81.7%
17,099
-77.0%
0.00%
-100.0%
Q2 2023$4,698,414
+61.6%
74,342
+15.0%
0.00%
+100.0%
Q1 2023$2,908,153
-8.9%
64,640
-11.3%
0.00%0.0%
Q4 2022$3,191,691
+110.5%
72,853
+216.7%
0.00%0.0%
Q3 2022$1,516,000
-3.9%
23,001
-26.3%
0.00%0.0%
Q2 2022$1,577,000
-48.8%
31,230
-35.2%
0.00%
Q1 2022$3,080,000
-28.0%
48,217
+20.7%
0.00%
-100.0%
Q4 2021$4,280,000
-39.6%
39,957
-42.0%
0.00%
-50.0%
Q3 2021$7,087,000
+7.4%
68,927
-8.1%
0.00%
-33.3%
Q2 2021$6,596,000
+150.3%
74,978
+176.7%
0.00%
+200.0%
Q1 2021$2,635,000
-70.9%
27,100
-66.5%
0.00%
-75.0%
Q4 2020$9,067,000
+36.0%
80,847
+12.4%
0.00%0.0%
Q3 2020$6,666,000
+3.1%
71,915
-13.2%
0.00%
-20.0%
Q2 2020$6,466,000
+227.2%
82,889
+145.3%
0.01%
+150.0%
Q1 2020$1,976,000
-67.8%
33,790
-55.9%
0.00%
-77.8%
Q4 2019$6,133,000
+165.6%
76,560
+143.6%
0.01%
+125.0%
Q3 2019$2,309,000
-24.5%
31,427
-3.1%
0.00%
-20.0%
Q2 2019$3,058,000
+196.6%
32,420
+151.7%
0.01%
+150.0%
Q1 2019$1,031,000
+400.5%
12,878
+296.7%
0.00%
Q2 2018$206,000
-82.8%
3,246
-81.1%
0.00%
-100.0%
Q3 2017$1,199,000
+137.4%
17,204
+36.2%
0.00%
+100.0%
Q1 2017$505,00012,6350.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders